[1]丁炎霖,屈 凯,祁海燕,等.名中医许建秦从“脾不散精”论治消渴经验[J].陕西中医,2024,(3):394-398.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.025]
　DING Yanlin,QU Kai,QI Haiyan,et al.Famous Chinese doctor Xu Jianqin discussed experience of treating Xiaoke from Pibu Sanjing[J].,2024,(3):394-398.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.025]
点击复制

名中医许建秦从“脾不散精”论治消渴经验
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年3期
页码:
394-398
栏目:
名中医经验
出版日期:
2024-03-05

文章信息/Info

Title:
Famous Chinese doctor Xu Jianqin discussed experience of treating Xiaoke from Pibu Sanjing
作者:
丁炎霖1; 屈 凯2; 祁海燕2; 刘厚利1; 刘月梅1; 周 婷1; 秦 登1; 武 云1; 谢 磊1; 许建秦2
(1.陕西中医药大学,陕西 咸阳710046; 2.陕西省中医药研究院,陕西 西安 710003)
Author(s):
DING Yanlin; QU Kai; QI Haiyan; LIU Houli; LIU Yuemei; ZHOU Ting; QIN Deng; WU Yun; XIE Lei; XU Jianqin
(Shaanxi University of Chinese Medicine,Xianyang 710046,China)
关键词:
消渴;  脾不散精;  脾虚湿阻;  气阴两虚;  瘀血内阻;  脾肾两虚
Keywords:
Xiaoke;  Pibu Sanjing;  Spleen deficiency dampness obstruction;  Qiyin Liangxu;  Yuxue Neizu;  Pishen Liangxu
分类号:
R 255.4
DOI:
DOI:10.3969/j.issn.1000-7369.2024.03.025
文献标志码:
A
摘要:
名中医许建秦从“脾不散精”论治消渴的辨证思路及遣方用药经验。许建秦主任医师认为,消渴与脾虚、脾不散精相关,涉及肾脏,其主要病机为脾不散精,运化机能减退,并将消渴发病分为前期(脾瘅期)、中期(消渴期)和后期(消瘅期)。许建秦认为,脾虚湿阻始终伴随着疾病演变过程,致精、气、血、津液的生成及代谢障碍,进而引起痰湿、瘀血、毒浊等病理产物,后期耗气伤阴,甚则累及五脏六腑,致气血阴阳俱虚。治疗上许建秦主任医师主张以助脾散精为法,结合病情发展阶段,辨证施治,以滋补脾肾为本,祛湿、消瘀为标。脾瘅期与消渴期注重健脾化湿,方选四君子汤加减。消渴期亦重视益气养阴、活血通络,选用自拟糖康方化裁。消渴日久导致肾精亏虚,治疗时以补脾益肾为主,调节气血阴阳。许建秦主任医师基于“脾不散精”理论治疗消渴,临床疗效较好。
Abstract:
Xu Jianqin,a famous Chinese medicine doctor,discussed dialectical thinking of treating Xiaoke from Pibu Sanjing and experience of dispensing prescription.Chief physician Xu Jianqin believes that Xiaoke is related to spleen deficiency and Pibu Sanjing,involving kidney.its main pathogenesis is Pibu Sanjing,transport machine can decrease,onset of Xiaoke is divided into early(spleen heat),middle(Xiaoke)and late(dissipating heat).Xu Jianqin believes that spleen deficiency and dampness always accompany evolution of the disease,resulting in production and metabolism of essence,Qi,blood and body fluid,and then cause phlegm dampness,blood stasis,toxic turbidity and other pathological products,in the later stage,Qi depletion and Yin injury,involving Wuzang Liiufu,resulting in deficiency of both Qixu Yin and Yang.In the treatment,chief physician Xu Jianqin advocated to help spleen to disperse essence as method,combined with development stage of the disease,syndrome differentiation treatment,based on tonifying the spleen and kidney,removing dampness and eliminating blood stasis as a standard.Spleen-heat and dipsoxia period pay attention to spleen-invigorating dampness,and choose Sijunzi decoction to reduce.During quenching period,pay attention to Yiqi Yangyin,promoting blood circulation and clearing collaterals.The kidney essence deficiency caused by long time of dispelling thirst,treatment mainly to tonify spleen and kidney,regulate Qixue Yinyang.Chief physician Xu Jianqin based on the Pibu Sanjing theory to treat Xiaoke,clinical effect is better.

参考文献/References:

[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].国际内分泌代谢杂志,2021,41(5):482-548.
[2] GREGORY G A,ROBINSON T I,LINKLATER S E,et al.Global incidence prevalence and mortality of type 1 diabetes in 2021 with projection to 2040:A modelling study[J].Diabetes & Endocrinology,2022,10(10):741-760.
[3] 中华医学会内分泌学分会.中国成人2型糖尿病口服降糖药联合治疗专家共识[J].中华内分泌代谢杂志,2019,35(3):190-199.
[4] 尚杰,刘淼,梁洋,等.中药活性成分治疗糖尿病及其并发症的研究进展[J].世界科学技术-中医药现代化,2022,24(5):1729-1737.
[5] 刘厚利,呼兴华,何莉,等.许建秦宣化汤治疗内伤湿热病证经验介绍[J].陕西中医,2020,41(6):802-804.
[6] 何莉,呼兴华,刘双,等.许建秦教授应用除痹止痛汤治疗痛风急性期经验[J].陕西中医,2021,42(9):1273-1275.
[7] 陈胡蓉,杨宇峰,董世彦,等.基于中医脏象理论构建消渴治疗框架[J].中国实验方剂学杂志,2020,26(11):200-205.
[8] 周莹,刘军彤,宁顺宇,等.从脾论治2型糖尿病研究进展[J].辽宁中医药大学学报,2023,25(8):93-98.
[9] 张成明,刘莹莹,郭亚男,等.中医脾脏本源探析[J].陕西中医,2022,43(2):227-230.
[10] 边文飞,黄延芹.中医药从脾胰同源理论干预胰腺疾病的研究进展[J].中国中医急症,2023,32(8):1479-1482.
[11] 魏代浩,张茜,魏皓月,等.基于葡萄糖激酶探讨“脾虚燥热”与血糖稳态失衡的关系[J].陕西中医,2023,44(4):475-478.
[12] 白程菲,许建秦,史亮,等.从“脾不散精”理论探讨糖尿病及其并发症的中医病机[J].国际中医中药杂志,2022,44(5):481-484.
[13] 崔长升,张羽,赵晋莹,等.基于网络药理学的黄精-党参联合治疗2型糖尿病作用机制研究[J].时珍国医国药,2020,31(3):571-575.
[14] 李燕,陈素红,吉星,等.白术多糖对自发性2型糖尿病小鼠血糖及相关指标的影响[J].中国实验方剂学杂志,2015,21(10):162-165.
[15] 王悦,田双双,刘晓谦,等.茯苓多糖的提取、结构及药理作用研究进展[J].世界中医药,2021,16(17):2548-2555.
[16] 刘月梅,张晓凤,刘厚利,等.许建秦治疗糖尿病周围神经病变气阴两虚兼血瘀证经验[J].陕西中医,2023,44(3):356-358.
[17] 周婷,屈凯,陈志永,等.名中医许建秦治疗气阴两虚兼血瘀型糖尿病周围神经病变的用药规律研究[J].陕西中医,2022,43(2):231-235.
[18] 王琪,柴单单,吴晓华,等.太子参多糖减轻高脂诱导的小鼠肝脏胰岛素抵抗[J].中国病理生理杂志,2015,31(4):685-689.
[19] 颉玙,张金梅,张敏,等.中药多糖修复糖尿病创面作用机制研究进展[J].中国实验方剂学杂志,2022,28(17):258-266.
[20] 马艳春,段莹,胡建辉,等.黄芪治疗糖尿病及其并发症研究进展[J].中医药学报,2022,50(6):103-107.
[21] 朱海瑀,管洪艺,闫慧新,等.中医药通过调控PI3K/Akt信号通路防治2型糖尿病肝脏胰岛素抵抗的研究进展[J].吉林中医药,2023,43(11):1356-1360.
[22] YIN X Y,XU Z Y,ZHANG Z Y et al.Association of PI3K/AKT/mTOR pathway genetic variants with type 2 diabetes mellitus in Chinese[J].Diabetes Res Clin Pract,2017,128(1):127-135.
[23] 孙秋峰.参芪麦味地黄汤治疗妊娠期首发不同程度糖耐量异常及改善母儿结局的研究[J].陕西中医,2017,38(2):221-223.
[24] 闫浩,刘小毛,左振宇,等.基于网络药理学探讨山茱萸抗糖尿病的作用机制研究[J].中华中医药学刊,2020,38(11):245-250.
[25] 王佐梅,肖洪彬,李雪莹,等.中药红花的药理作用及临床应用研究进展[J].中华中医药杂志,2021,36(11):6608-6611.

相似文献/References:

[1]李 捷,郑雅峰,沈瑛锴,等.基于“一气周流”理论思想探析2型糖尿病的辨治思路[J].陕西中医,2023,(12):1762.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.021]
　LI Jie,ZHENG Yafeng,SHEN Yingkai,et al.The differentiation and treatment of type 2 diabetes mellitus based on the theory of “Yiqi Zhouliu”[J].,2023,(3):1762.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.021]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81603454); 国家中医药管理局中医药科学技术研究专项课题(GZY-KJS-2021-005)
更新日期/Last Update: 2024-03-08